Material Agreements

NATURAL HEALTH TRENDS CORP entered into Repurchase Agreement with George K. Broady 2012 Irrevocable Trust and the Eleanor Jane Broady 2012 Irrevocable Trust valued at approximately $5.9 million (effective 2026-02-17).

“On February 17, 2026, Natural Health Trends Corp. (the “Company”) entered into a share repurchase agreement (the “Repurchase Agreement”) with the George K. Broady 2012 Irrevocable Trust and the Eleanor Jane Broady 2012 Irrevocable Trust (collectively, the “Sellers”).”

MASIMO CORP entered into Voting and Support Agreement with Politan Capital Management LP (effective 2026-02-16).

“(ii) a Voting and Support Agreement (the “ Voting Agreement ”), with Parent, Merger Sub and Politan Capital Management LP (“ Politan ”)”

MASIMO CORP entered into Agreement and Plan of Merger with Danaher Corporation and Mobius Merger Sub, Inc. valued at $180.00 in cash, without interest (effective 2026-02-16).

“On February 16, 2026, Masimo Corporation (the “ Company ”) entered into (i) an Agreement and Plan of Merger (the “ Merger Agreement ”) with Danaher Corporation, a Delaware corporation (“ Parent ”), and Mobius Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“ Merger Sub ”)”

TRANSACT TECHNOLOGIES INC entered into Lease with Constantino Noval Nevada 3, LLC (effective 2026-02-09).

“On February 9, 2026, TransAct Technologies Incorporated (the “Company”) entered into a lease agreement (the “Lease”) with Constantino Noval Nevada 3, LLC (the “Landlord”) to lease approximately 9,427 square feet of office space”

OLENOX INDUSTRIES INC. entered into Settlement Agreement with Cedar Advance LLC valued at $1,732,500 (effective 2026-02-10).

“On February 10, 2026 (the “Effective Date”), Olenox Industries Inc. (the “Company”), executed a mutual settlement and release agreement (the “Settlement Agreement”) with Cedar Advance LLC (“Cedar”), to resolve the outstanding balance of $1,732,500 (the “Balance”) owed by the Company pursuant to those certain Standard Merchant Cash Advance Agreements between the Company and Cedar.”

W. P. Carey Inc. entered into Underwriting Agreement with J.P. Morgan Securities plc, Barclays Bank PLC, BNP PARIBAS and Wells Fargo Securities International Limited as representatives of the several underwriters valued at €1.0 billion (effective 2026-02-12).

“On February 12, 2026, W. P. Carey Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with J.P. Morgan Securities plc, Barclays Bank PLC, BNP PARIBAS and Wells Fargo Securities International Limited as representatives of the several underwriters listed in Schedule 1 to the Underwriting Agreement (collectively, the “ Underwriters ”), in connection with the public offering (the “ Offering ”) of €1.0 billion in aggregate principal amount of senior unsecured notes”

HUNTSMAN INTERNATIONAL LLC terminated credit agreement, dated as of May 20, 2022 with Citibank, N.A., as Administrative Agent, and the lenders party thereto (effective 2026-02-09).

“HI terminated all commitments and repaid all obligations under HI’s existing credit agreement, dated as of May 20, 2022, among HI, Citibank, N.A., as Administrative Agent, and the lenders party thereto (as previously amended, restated, amended and restated, supplemented or otherwise modified).”

HUNTSMAN INTERNATIONAL LLC entered into Credit Agreement with Citibank, N.A., as Administrative Agent and Collateral Agent, and the lenders thereto valued at $800 million (effective 2026-02-09).

“Huntsman International LLC (“HI”), a wholly-owned subsidiary of Huntsman Corporation, entered into a Credit Agreement with Citibank, N.A., as Administrative Agent and Collateral Agent, and the lenders thereto, in connection with an $800 million senior secured revolving credit facility (the “Credit Agreement”).”

SYNCHRONOSS TECHNOLOGIES INC terminated Receivables Purchase Agreement, dated as of June 22, 2022 with Norddeutsche Landesbank Girozentrale valued at All outstanding liabilities and obligations paid in full; liens and guarantees released (effective 2025-12-04).

“In connection with the consummation of the Merger, on the Closing Date, the Company and certain of its subsidiaries terminated all outstanding obligations under that certain Receivables Purchase Agreement, dated as of June 22, 2022 (as amended, restated, modified or supplemented from time to time, the “ Receivables Purchase Agreement ” ), among SN Technologies, LLC, SN Technologies, Inc., the Purchasers party thereto, the Group Agents party thereto, and Norddeutsche Landesbank Girozentrale, as administrative agent.”

SYNCHRONOSS TECHNOLOGIES INC terminated Credit Agreement, dated as of June 28, 2024, as amended by First Amendment dated April 24, 2025 with BGC Lender Rep LLC valued at All outstanding commitments terminated; obligations for principal, interest and fees paid in full; l (effective 2025-12-04).

“In connection with the consummation of the Merger, on the Closing Date, the Company terminated all outstanding commitments, including commitments to issue letters of credit, under that certain Credit Agreement, dated as of June 28, 2024, by and among the Company, the lenders party thereto and BGC Lender Rep LLC, as administrative agent, as amended by that certain First Amendment to Credit Agreement and Pledge and Security Agreement, dated as of April 24, 2025, by and among the Company and the parties thereto (the “ Credit Agreement ”).”

BRAINSTORM CELL THERAPEUTICS INC. entered into Securities Purchase Agreement with an accredited investor valued at $1,000,000 (effective 2026-02-09).

“On February 9, 2026, Brainstorm Cell Therapeutics Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with an accredited investor (the “ Investor ”), pursuant to which the Company agreed to sell, in a private placement, shares of its common stock, par value $0.00005 per share (the “ Common Stock ”), and, in lieu of shares as elected by an investor, pre-funded warrants to purchase Common Stock (the “ Pre-Funded Warrants ).”

Cencora, Inc. entered into Twenty-Second Supplemental Indenture with U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee valued at $500,000,000 aggregate principal amount (effective 2026-02-13).

“The 2056 Notes were issued under and are governed by the Base Indenture, as supplemented and amended by a Twenty-Second Supplemental Indenture, dated as of February 13, 2026, by and between the Company and the Trustee (the “Twenty-Second Supplemental Indenture” and, together with the Base Indenture, the “2056 Note Indenture”).”

Cencora, Inc. entered into Twenty-First Supplemental Indenture with U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee valued at $1,000,000,000 aggregate principal amount (effective 2026-02-13).

“The 2036 Notes were issued under and are governed by the Base Indenture, as supplemented and amended by a Twenty-First Supplemental Indenture, dated as of February 13, 2026, by and between the Company and the Trustee (the “Twenty-First Supplemental Indenture” and, together with the Base Indenture, the “2036 Note Indenture”).”

Cencora, Inc. entered into Twentieth Supplemental Indenture with U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee valued at $500,000,000 aggregate principal amount (effective 2026-02-13).

“The 2033 Notes were issued under and are governed by the Base Indenture, as supplemented and amended by a Twentieth Supplemental Indenture, dated as of February 13, 2026, by and between the Company and the Trustee (the “Twentieth Supplemental Indenture” and, together with the Base Indenture, the “2033 Note Indenture”).”

Cencora, Inc. entered into Nineteenth Supplemental Indenture with U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee valued at $500,000,000 aggregate principal amount (effective 2026-02-13).

“The 2030 Notes were issued under and are governed by the Base Indenture, as supplemented and amended by a Nineteenth Supplemental Indenture, dated as of February 13, 2026, by and between the Company and the Trustee (the “Nineteenth Supplemental Indenture” and, together with the Base Indenture, the “2030 Note Indenture”).”

Cencora, Inc. entered into Eighteenth Supplemental Indenture with U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee valued at $500,000,000 aggregate principal amount (effective 2026-02-13).

“The 2029 Notes were issued under and are governed by an Indenture, dated as of November 19, 2009 (the “Base Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the “Trustee”), as supplemented and amended by an Eighteenth Supplemental Indenture, dated as of February 13, 2026, by and between the Company and the Trustee (the “Eighteenth Supplemental Indenture” and, together with the Base Indenture, the “2029 Note Indenture”).”

RED ROBIN GOURMET BURGERS INC amended Amended Cooperation Agreement with JCP Parties and Jumana Parties (Investor Parties) (effective 2026-02-13).

“On February 13, 2026, Red Robin Gourmet Burgers, Inc. (the “Company”) amended the Cooperation Agreement, dated December 3, 2024 (the “Amended Cooperation Agreement”) with the entities and persons listed on Exhibit A thereto (the “JCP Parties”) and the entities and persons listed on Exhibit B thereto (the “Jumana Parties,” and together with the JCP Parties, the “Investor Parties”).”

TransDigm Group INC amended Amendment No. 20 and Incremental Term Loan Assumption Agreement with Goldman Sachs Bank USA valued at $800,000,000 Tranche N Term Loans (effective 2026-02-13).

“AMENDMENT NO. 20 and INCREMENTAL TERM LOAN ASSUMPTION AGREEMENT dated as of February 13, 2026, relating to the SECOND AMENDED AND RESTATED CREDIT AGREEMENT dated as of June 4, 2014, among TRANSDIGM INC., TRANSDIGM GROUP INCORPORATED, THE SUBSIDIARIES OF TRANSDIGM INC. FROM TIME TO TIME PARTY THERETO, THE LENDERS PARTY THERETO and GOLDMAN SACHS BANK USA, as Administrative Agent and Collateral Agent”

IMMUNIC, INC. entered into Securities Purchase Agreement with certain accredited investors valued at approximately $200 million (effective 2026-02-12).

“On February 12, 2026, Immunic Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with certain accredited investors (the “ Investors ”), pursuant to which the Company agreed to issue and sell, in a private placement (the “ Offering ”), pre-funded warrants”

Iveda Solutions, Inc. entered into Purchase Agreement with certain institutional investors (effective 2026-02-09).

“the Company also entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors who purchased shares of Common Stock, Pre-Funded Warrants and Series X Warrants in this Offering.”

AMC ENTERTAINMENT HOLDINGS, INC. amended Supplemental Indenture with CSC Delaware Trust Company (effective 2026-02-12).

“On February 12 , 2026, AMC, Muvico, the other guarantors party thereto and CSC Delaware Trust Company, as trustee and notes collateral agent, entered into a supplemental indenture”

Pebblebrook Hotel Trust amended Fourth Amendment to Fifth Amended and Restated Credit Agreement with Bank of America, N.A. valued at Term Loan A-3 extended to 2031; Revolver capacity $650 million with initial maturity October 13, 202 (effective 2026-02-11).

“On February 11, 2026, Pebblebrook Hotel Trust (the “ Company ”), as parent guarantor, Pebblebrook Hotel, L.P. (the “ Operating Partnership ”), as borrower, and certain subsidiaries of the Operating Partnership, as guarantors, Bank of America, N.A. (“ BofA ”), as administrative agent and L/C issuer, and certain other lenders named therein, entered into the Fourth Amendment to Fifth Amended and Restated Credit Agreement (the “ Credit Agreement Amendment ”) to amend the Fifth Amended and Restated Credit Agreement, dated October 13, 2022, among the Company, the Operating Partnership, certain subsidiaries of the Operating Partnership, BofA and certain other lenders named therein (as amended by the First Amendment to Fifth Amended and Restated Credit Agreement, dated January 3, 2024, the Second Amendment to Fifth Amended and Restated Credit Agreement, dated September 18, 2024, and the Third Amendment to Fifth Amended and Restated Credit Agreement, dated November 11, 2026, “ Credit Agreement”

SUNHYDROGEN, INC. entered into Technology and Manufacturing Services Agreement with CTF Solar GmbH valued at up to €2,000,000 (approximately $2,370,000) (effective 2026-02-09).

“On February 9, 2026, SunHydrogen, Inc. (the "Company") entered into a Technology and Manufacturing Services Agreement (the "Services Agreement") with CTF Solar GmbH ("CTF").”

Streamex Corp. terminated Yorkville Debentures with YA II PN, LTD. valued at aggregate cash payoff amount of $38,902,740 (effective 2026-02-06).

“the Company pre-paid the remaining amounts due under the Yorkville Debentures for an aggregate cash payoff amount of $38,902,740”

Tri Pointe Homes, Inc. entered into Agreement and Plan of Merger with Sumitomo Forestry Co., Ltd. valued at $47.00 per share in cash (effective 2026-02-13).

“On February 13, 2026, Tri Pointe Homes, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Sumitomo Forestry Co., Ltd., a Japanese corporation ( kabushiki kaisha ) (“ Parent ”), and Teton NewCo, Inc., a Delaware corporation and an indirect wholly owned Subsidiary of Parent (“ Merger Sub ”), providing for the merger of Merger Sub with and into the Company, with the Company continuing as the surviving corporation (the “ Merger ”).”

OXBRIDGE RE HOLDINGS Ltd entered into Promissory Note with Real World Digital Assets LLC valued at $1,000,000 (effective 2026-02-11).

“On February 11, 2026, Oxbridge Re Holdings Limited (the “Company”) entered into a Promissory Note (the “Note”) with Real World Digital Assets LLC (the “Lender”), pursuant to which the Company borrowed $1,000,000 in principal amount.”

Funko, Inc. amended Fifth Amendment with JPMorgan Chase Bank, N.A. (effective 2026-02-13).

“On February 13, 2026, Funko Acquisition Holdings, L.L.C. (the “Company”), a subsidiary of Funko, Inc., and certain of the Company’s material domestic subsidiaries (collectively, the “Credit Agreement Parties”) entered into an amendment (the “Fifth Amendment”) with the lenders party to the Existing Credit Agreement (as defined below) and JPMorgan Chase Bank, N.A. as administrative agent (“JPM”).”

Monroe Capital Income Plus Corp amended Seventh Amendment to Amended and Restated Revolving Credit and Security Agreement with MC Income Plus Financing SPV LLC, KeyBank National Association, U.S. Bank Trust Company, National Association, U.S. Bank National Association (effective 2026-02-10).

“On February 10, 2026, Monroe Capital Income Plus Corporation (the “Company”), entered into the Seventh Amendment to Amended and Restated Revolving Credit and Security Agreement (“Seventh Amendment”), by and among MC Income Plus Financing SPV LLC, a wholly-owned subsidiary of the Company, as borrower, the Company, as collateral manager, the lenders party thereto, KeyBank National Association, as administrative agent and as lead arranger, U.S. Bank Trust Company, National Association, as collateral agent and as collateral administrator, and U.S. Bank National Association, as document custodian.”

NEXTNRG, INC. entered into Stock Purchase Agreement with an investor (the "Purchaser") valued at $225,000 (effective 2026-02-12).

“On February 12, 2026, NextNRG, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “February 12 SPA”) with an investor (the “Purchaser”). Pursuant to the terms of the February 12 SPA, the Company agreed to sell, and the Purchaser agreed to purchase, 300,000 shares of the Company’s common stock at a purchase price of $225,000, representing a price per share of $0.75.”

SOCIETY PASS INCORPORATED. entered into Purchase Agreement with certain investors valued at approximately $2.5 million (effective 2026-02-11).

“Certain investors purchasing securities in the Offering entered into a securities purchase agreement with the Company (the “Purchase Agreement”), dated as of February 11, 2026.”

Phoenix Energy One, LLC amended Amendment No. 8 to Amended and Restated Senior Secured Credit Agreement with Fortress Credit Corp. valued at $75 million in Amendment No. 7 Discretionary Delayed Draw Term Loan Commitments drawn, reducing avai (effective 2026-02-12).

“On February 12, 2026 (the “ Amendment No. 8 Effective Date ”), the Company, Phoenix Operating, the Guarantors party thereto, the Specified Additional Guarantor, the Lenders party thereto, and Fortress entered into that certain Amendment No. 8 to Amended and Restated Senior Secured Credit Agreement (“ Amendment No. 8 ”).”

Banzai International, Inc. entered into Purchase Agreement with an institutional investor valued at up to an aggregate original principal amount of $11,000,000 (effective 2025-06-27).

“Banzai International, Inc. (the “ Company ”) previously reported that it entered into a securities purchase agreement (the “ Purchase Agreement ”) on June 27, 2025, with an institutional investor (the “ Buyer ”) for the issuance and sale in a private placement (the “ Offering ”) of senior secured convertible notes of the Company, of up to an aggregate original principal amount of $11,000,000”

HCW Biologics Inc. entered into a license with WY Biotech Co., Ltd. (effective 2026-02-13).

“On February 13, 2026, HCW Biologics Inc. and WY Biotech Co., Ltd. (“WY Biotech”), a China-based company specializing in the early-stage development of recombinant protein drugs and gene/cell therapies, today jointly announced the commencement of an exclusive worldwide license agreement covering the development and commercialization rights for certain in vivo applications for one of HCW Biologics’ proprietary molecules, HCW11-006.”

Nuvve Holding Corp. terminated master services agreement with Fresno Economic Opportunities Commission valued at approximately $15.7 million (effective 2026-02-11).

“On February 11, 2026, Nuvve Holding Corp. (the “Company”) determined that the master services agreement, dated May 14, 2024 (the “Agreement”), by and between the Company and Fresno Economic Opportunities Commission (the “FEOC”) had been effectively terminated”

Envoy Medical, Inc. entered into Pre-Funded Warrants with certain investors valued at 27,053,850 Pre-Funded Warrants to purchase 27,053,850 shares of Common Stock at an exercise price of (effective 2026-02-11).

“ii) 27,053,850 pre-funded warrants (the “ Pre-Funded Warrants ”) to purchase 27,053,850 shares of Common Stock, (iii) 45,000,000 Series A-1 Warrants to purchase 45,000,000 shares of Common Stock and/or pre-funded warrants (the “ Series”

Envoy Medical, Inc. entered into Engagement Letter with H.C. Wainwright & Co., LLC valued at exclusive placement agent for the Offering (effective 2025-09-17).

“H.C. Wainwright & Co., LLC (“ Wainwright ”) acted as the exclusive placement agent for the Offering pursuant to an Engagement Letter, dated September 17, 2025, as amended on December 17, 2025, February 9, 2026 and February 11, 2026 (the “ Engagement Letter ”).”

Envoy Medical, Inc. entered into Securities Purchase Agreement with certain investors valued at aggregate gross proceeds of approximately $30.0 million from the Offering (effective 2026-02-11).

“On February 11, 2026, Envoy Medical, Inc., a Delaware corporation (the “ Company ”), commenced a best efforts public offering (the “ Offering ”) of an aggregate of (i) 47,946,150 shares (the “ Shares ”) of the Company’s Class A Common Stock, par value $0.0001 per share (“ Common Stock ”), (ii) 27,053,850 pre-funded warrants (the “ Pre-Funded Warrants ”) to purchase 27,053,850 shares of Common Stock, (iii) 45,000,000 Series A-1 Warrants to purchase 45,000,000 shares of Common Stock and/or pre-funded warrants (the “ Series A-1 Warrants ”), and (iv) 75,000,000 Series A-2 Warrants to purchase 75,000,000 shares of Common Stock and/or pre-funded warrants (the “ Series A-2 Warrants ” and, together with the Series A-1 Warrants, the “ Common Warrants ”).”

FLYEXCLUSIVE INC. amended Amended and Restated Agreement and Plan of Merger and Reorganization with Jet.AI Inc., Jet.AI SpinCo, Inc., and FlyX Merger Sub, Inc. (effective 2026-02-11).

“On February 11, 2026, the parties to the A&R Merger Agreement, as amended, executed Amendment No. 4 to the A&R Merger Agreement, as amended (“Amendment No. 4”).”

Profusa, Inc. entered into License Agreement with Mayo Foundation for Medical Education and Research (effective 2026-02-11).

“On February 11, 2026, Profusa, Inc. (the “Company”) entered into a know-how license agreement (the “License Agreement”) with Mayo Foundation for Medical Education and Research (“Mayo”).”

CERO THERAPEUTICS HOLDINGS, INC. entered into Note with Keystone Capital Partners, LLC valued at $750,000 (effective 2026-02-09).

“On February 9, 2026, CERo Therapeutics Holdings, Inc., a Delaware corporation (the “Company”) issued and sold a convertible promissory note for a purchase price of $750,000, having a principal face value of $937,500 (the “Note”) to Keystone Capital Partners, LLC (“Lender”).”

AB Private Lending Fund amended Amendment with the lenders referred to therein, the Bank of Nova Scotia, as administrative agent, U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, and U.S. Bank National Association, as custodian (effective 2026-02-09).

“On February 9, 2026, ABPLF SPV I LLC (the “ Borrower ”), a wholly-owned subsidiary of AB Private Lending Fund (the “ Fund ”), entered into the second amendment (the “ Amendment ”) to that certain credit agreement (the “ Credit Agreement ”) establishing its warehouse credit facility (the “ ABPLF Credit Facility ”) among the Borrower, the lenders referred to therein, the Bank of Nova Scotia, as administrative agent, U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, and U.S. Bank National Association, as custodian.”

Wellgistics Health, Inc. entered into Settlement Agreement and Stipulation with Silverback Capital Corporation valued at Settlement of aggregate principal amount of not less than $10,712,734.16 in liabilities via issuance (effective 2026-01-28).

“Previously, on January 28, 2026, the Company and SCC entered into a Settlement Agreement and Stipulation (the “Settlement Agreement”), pursuant to which SCC agreed to acquire and settle certain bona fide liabilities and obligations of the Company in an aggregate principal amount of not less than $10,712,734.16 (the “Claim Amount”) (the “Settlement”).”

New Mountain Private Credit Fund entered into Loan Agreement with NMF Investments III, L.L.C. valued at maximum borrowings of up to $50.0 million (effective 2026-02-09).

“On February 9, 2026, New Mountain Private Credit Fund (the “ Company ”) entered into an uncommitted revolving loan agreement (the “ Loan Agreement ”) with NMF Investments III, L.L.C., as the lender (the “ Lender ”), and the Company, as borrower.”

Evommune, Inc. entered into Registration Rights Agreement with certain investors (effective 2026-02-12).

“In connection with the Private Placement, the Company also entered into a Registration Rights Agreement, dated February 12, 2026 (the “Registration Rights Agreement”), with the Investors.”

Evommune, Inc. entered into Securities Purchase Agreement with certain investors valued at approximately $125 million (effective 2026-02-12).

“On February 12, 2026, Evommune, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Investors”) pursuant to which the Company, in a private placement (the “Private Placement”), agreed to issue and sell to the Investors an aggregate of 4,494,279 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Each Share was offered and sold at a purchase price of $27.88 before deducting underwriting discounts and commissions. The Private Placement is expected to close on or about February 17, 2026, subject to the satisfaction of customary closing conditions. The Company estimates that the gross proceeds to the Company from the Private Placement will be approximately $125 million, before deducting any transaction-related expenses.”

Columbus Circle Capital Corp II entered into Sponsor Private Placement Units Purchase Agreement with Columbus Circle 2 Sponsor Corporation LLC (effective 2026-02-10).

“A Private Placement Units Purchase Agreement, dated February 10, 2026 (the “ Sponsor Private Placement Units Purchase Agreement ”), by and between the Company and Columbus Circle 2 Sponsor Corporation LLC, a Delaware limited liability company (the “ Sponsor ”)”

Columbus Circle Capital Corp II entered into Registration Rights Agreement with certain security holders (effective 2026-02-10).

“● A Registration Rights Agreement, dated February 10, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.”

Columbus Circle Capital Corp II entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-10).

“An Investment Management Trust Agreement, dated February 10, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee”

Columbus Circle Capital Corp II entered into Warrant Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-10).

“A Warrant Agreement, dated February 10, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent”

Columbus Circle Capital Corp II entered into Underwriting Agreement with Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, and Clear Street LLC, as representatives of the several underwriters (effective 2026-02-10).

“An Underwriting Agreement, dated February 10, 2026, by and between the Company and Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, and Clear Street LLC, as representatives of the several underwriters”